Last reviewed · How we verify

NCT05140291

Dry Needling for Cervicogenic Headache

Status unknown NA Last updated 11 January 2022
What this trial tests

NA trial testing Dry Needling in Headache in 30 participants. Status unknown.

Timeline
3 December 2021
Primary endpoint
30 April 2022
30 April 2022

Quick facts

Lead sponsorYoungstown State University
PhaseNA
StatusStatus unknown
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingtriple
Primary purposetreatment
Enrollment30
Start date3 December 2021
Primary completion30 April 2022
Estimated completion30 April 2022
Sites1 location across United States

Drugs / interventions tested

Conditions studied

Sponsor

Youngstown State University

Who can join

18 and older, any sex, with Headache. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Currently, it is unknown if dry needling when performed to the trigeminal innervation field improves neck pain and or headache for patients with cervicogenic headaches. The aim of this study is to determine if dry needling of the trigeminal innervation field improves pain, pain-pressure thresholds, and neck mobility in patients with cervicogenic headaches, with or without migraine.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of Dry Needling

Trials testing the same drug.

Other recruiting trials for Headache

Currently open trials in the same condition.

Other Youngstown State University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05140291.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing